|
|
 |
ACTOPLUS MET Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ALECENSA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ANHYDROUS CITRIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ANHYDROUS TRISODIUM CITRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
BENZETHONIUM CHLORIDE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
DOCUSATE SODIUM Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|